We're advancing micro-encapsulation technology solutions. Effective delivery of bioactives (including probiotics) via micro-encapsulation is still an industry-wide issue. The technology is not yet mature enough to provide adequate and prolonged stability or efficiently deliver to the target site in the body. We at Mello are changing the game for bioactive delivery. We're working closely with Danish Technological Institute to develop the first water-free process, necessary to generate a lipid-based TrueCoreTM particle at micro size. We're building a delivery platform for different bioactives. We aim to be THE market leader in delivery solutions for sensitive and unstable 'actives'.